Huntington's disease phenocopies are clinically and genetically heterogeneous
- PMID: 18181206
- DOI: 10.1002/mds.21915
Huntington's disease phenocopies are clinically and genetically heterogeneous
Abstract
Huntington's disease (HD) classically presents with movement disorder, cognitive dysfunction and behavioral problems but is phenotypically variable. One percent of patients with HD-like symptoms lack the causative mutation and are considered HD phenocopies. Genetic diseases known to cause HD phenocopies include HD-like syndromes HDL1, HDL2, and HDL4 (SCA17). HD has phenotypic overlap with dentatorubral-pallidoluysian atrophy, the spinocerebellar ataxias and neuroferritinopathy. Identifying the genetic basis of HD phenocopies is important for diagnosis and may inform the search for HD genetic modifiers. We sought to identify neurogenetic diagnoses in the largest reported cohort of HD phenocopy patients. Two hundred eighty-five patients with syndromes consistent with HD, who were HD expansion-negative, were screened for mutations in PRNP, JPH3, TBP, DRPLA, SCA1, SCA2, SCA3, FTL and FRDA. Genetic diagnoses were made in 8 subjects: we identified 5 cases of HDL4, 1 of HDL1 and 1 of HDL2. One patient had Friedreich's ataxia. There were no cases of DRPLA, SCA1, SCA2, SCA3, or neuroferritinopathy. HD phenocopies are clinically and genetically diverse and a definitive genetic diagnosis is currently possible in only a minority of cases. When undertaken, it should be clinically directed and patients and clinicians should be prepared for the low probability of reaching a genetic diagnosis in this group of patients.
2008 Movement Disorder Society
Similar articles
-
Genetic screening of Greek patients with Huntington’s disease phenocopies identifies an SCA8 expansion.J Neurol. 2012 Sep;259(9):1874-8. doi: 10.1007/s00415-012-6430-9. J Neurol. 2012. PMID: 22297462
-
Huntington's disease phenocopy syndromes.Curr Opin Neurol. 2007 Dec;20(6):681-7. doi: 10.1097/WCO.0b013e3282f12074. Curr Opin Neurol. 2007. PMID: 17992089 Review.
-
Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes.Brain. 2003 Jul;126(Pt 7):1599-603. doi: 10.1093/brain/awg155. Epub 2003 May 6. Brain. 2003. PMID: 12805114
-
Huntington disease and Huntington disease-like in a case series from Brazil.Clin Genet. 2014 Oct;86(4):373-7. doi: 10.1111/cge.12283. Epub 2013 Oct 17. Clin Genet. 2014. PMID: 24102565
-
The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test.Nat Clin Pract Neurol. 2007 Sep;3(9):517-25. doi: 10.1038/ncpneuro0606. Nat Clin Pract Neurol. 2007. PMID: 17805246 Review.
Cited by
-
Transcriptome-wide association analysis of brain structures yields insights into pleiotropy with complex neuropsychiatric traits.Nat Commun. 2021 May 17;12(1):2878. doi: 10.1038/s41467-021-23130-y. Nat Commun. 2021. PMID: 34001886 Free PMC article.
-
Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review.J Neurol. 2022 Feb;269(2):676-692. doi: 10.1007/s00415-021-10461-5. Epub 2021 Mar 1. J Neurol. 2022. PMID: 33649871 Free PMC article.
-
Screening for the C9ORF72 expansion in Greek Huntington Disease phenocopies and controls and meta-analysis of current data.Tremor Other Hyperkinet Mov (N Y). 2020 Jun 12;10:5. doi: 10.5334/tohm.61. Tremor Other Hyperkinet Mov (N Y). 2020. PMID: 32775019 Free PMC article.
-
Xeroderma pigmentosum is a definite cause of Huntington's disease-like syndrome.Ann Clin Transl Neurol. 2017 Dec 4;5(1):102-108. doi: 10.1002/acn3.511. eCollection 2018 Jan. Ann Clin Transl Neurol. 2017. PMID: 29376097 Free PMC article.
-
Huntington's disease: progress toward effective disease-modifying treatments and a cure.Hum Mol Genet. 2010 Apr 15;19(R1):R98-R102. doi: 10.1093/hmg/ddq148. Epub 2010 Apr 26. Hum Mol Genet. 2010. PMID: 20421366 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous